{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:35:38Z","timestamp":1773869738464,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.hpb.2016.03.609","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T15:44:21Z","timestamp":1462117461000},"page":"593-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7\/8) hepatocellular carcinoma (HCC)"],"prefix":"10.1016","volume":"18","author":[{"given":"Neal","family":"Bhutiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prejesh","family":"Philips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles R.","family":"Scoggins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly M.","family":"McMasters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa H.","family":"Potts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2016.03.609_bib1","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4254\/wjh.v7.i9.1184","article-title":"Intermediate hepatocellular carcinoma: how to choose the best treatment modality?","volume":"7","author":"Di Costanzo","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hpb.2016.03.609_bib2","first-page":"442","article-title":"New treatment modalities for hepatocellular cancer","volume":"17","author":"Mauer","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"issue":"5 Suppl.\u00a01","key":"10.1016\/j.hpb.2016.03.609_bib3","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1053\/j.gastro.2004.09.031","article-title":"Thermal ablation for hepatocellular carcinoma","volume":"127","author":"Head","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2016.03.609_bib4","article-title":"Percutaneous thermal ablation for primary hepatocellular carcinoma: a systematic review and meta-analysis","author":"Chinnaratha","year":"2015","journal-title":"Ultrasonography"},{"key":"10.1016\/j.hpb.2016.03.609_bib5","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4254\/wjh.v7.i15.1913","article-title":"Current management of patients with hepatocellular carcinoma","volume":"7","author":"Kanda","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hpb.2016.03.609_bib6","first-page":"217","article-title":"Minimally invasive local therapies for liver cancer","volume":"11","author":"Li","year":"2014","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.hpb.2016.03.609_bib7","article-title":"Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients","author":"Santambrogio","year":"2015","journal-title":"Surg Endosc"},{"key":"10.1016\/j.hpb.2016.03.609_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archsurg.141.2.181","article-title":"Radiofrequency ablation of liver tumors: a systematic review","volume":"141","author":"Sutherland","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.hpb.2016.03.609_bib9","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/bjs.7669","article-title":"Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma","volume":"98","author":"Tiong","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2016.03.609_bib10","first-page":"219","article-title":"Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location","volume":"69","author":"Toshimori","year":"2015","journal-title":"Acta medica Okayama"},{"key":"10.1016\/j.hpb.2016.03.609_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12957-015-0516-7","article-title":"Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials","volume":"13","author":"Yang","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hpb.2016.03.609_bib12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ejrad.2015.02.027","article-title":"Microwave ablation of focal hepatic malignancies regardless of size: a 9-year retrospective study of 64 patients","volume":"84","author":"Alexander","year":"2015","journal-title":"Eur J Radiology"},{"key":"10.1016\/j.hpb.2016.03.609_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s11547-015-0550-0","article-title":"Percutaneous treatment of Hepatocellular carcinoma exceeding 3 cm: combined therapy or microwave ablation? Preliminary results","author":"Veltri","year":"2015","journal-title":"La Radiol medica"},{"key":"10.1016\/j.hpb.2016.03.609_bib14","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.crad.2015.06.092","article-title":"High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence","volume":"70","author":"Zhang","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.hpb.2016.03.609_bib15","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1148\/radiol.2343040153","article-title":"Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver","volume":"234","author":"Lu","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.hpb.2016.03.609_bib16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/cncr.11168","article-title":"Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation","volume":"97","author":"Komorizono","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2016.03.609_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3348\/kjr.2009.10.4.366","article-title":"Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy","volume":"10","author":"Kim","year":"2009","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.hpb.2016.03.609_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11605-013-2164-y","article-title":"Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes","volume":"17","author":"Swan","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2016.03.609_bib19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jso.23280","article-title":"Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures","volume":"107","author":"Cannon","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2016.03.609_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0033-1333655","article-title":"Irreversible electroporation of hepatic malignancy","volume":"30","author":"Narayanan","year":"2013","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.hpb.2016.03.609_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/153303460700600404","article-title":"Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation","volume":"6","author":"Lee","year":"2007","journal-title":"Technol Cancer Res Treat"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.hpb.2016.03.609_bib22","doi-asserted-by":"crossref","first-page":"v59","DOI":"10.1093\/annonc\/mdq166","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Jelic","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2016.03.609_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/1471-2407-14-540","article-title":"Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation","volume":"14","author":"Martin","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2016.03.609_bib24","doi-asserted-by":"crossref","first-page":"e22786","DOI":"10.5812\/aapm.22786","article-title":"Intra - operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors","volume":"5","author":"Martin","year":"2015","journal-title":"Anesthesiol Pain Med"},{"key":"10.1016\/j.hpb.2016.03.609_bib25","doi-asserted-by":"crossref","first-page":"e76260","DOI":"10.1371\/journal.pone.0076260","article-title":"Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated","volume":"8","author":"Philips","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2016.03.609_bib26","unstructured":"Pearson R, Lovewell, JG, Warden D, Morrison, DL, Sarno, TR, Lai, HT, Hamilton, WC, Jr., Davalos, RV, Robert, EN II, inventor Robert M. Pearson, James G. Lovewell, David Warden, David Lee Morrison, Tony R. Sarno, Hy Truong Lai, William C. Hamilton, Jr., Rafael Vidal Davalos, E. Neal II Robert, assignee. System and method for interactively planning and controlling a treatment of a patient with a medical treatment device USA patent US20100249771 A1. 2010."},{"key":"10.1016\/j.hpb.2016.03.609_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2016.03.609_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1245\/s10434-009-0686-z","article-title":"Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience","volume":"17","author":"Martin","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2016.03.609_bib29","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jvir.2015.05.014","article-title":"Irreversible electroporation can effectively ablate hepatocellular carcinoma to complete Pathologic necrosis","volume":"26","author":"Cheng","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.hpb.2016.03.609_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7785\/tcrt.2012.500317","article-title":"Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes","volume":"12","author":"Cheung","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.hpb.2016.03.609_bib31","doi-asserted-by":"crossref","first-page":"e76119","DOI":"10.1371\/journal.pone.0076119","article-title":"Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.hpb.2016.03.609_bib32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1148\/radiology.217.3.r00dc26633","article-title":"Tumor ablation with radio-frequency energy","volume":"217","author":"Gazelle","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.hpb.2016.03.609_bib33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/gut.2004.045203","article-title":"Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less","volume":"54","author":"Lin","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2016.03.609_bib34","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.jvir.2013.01.103","article-title":"Irreversible electroporation (IRE) in cirrhotic liver: preliminary experience in a large animal model","volume":"24","author":"Abdelsalam","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.hpb.2016.03.609_bib35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jvir.2015.02.001","article-title":"Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study","volume":"26","author":"Niessen","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X16316306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X16316306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:06:52Z","timestamp":1761264412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X16316306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1365182X16316306"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2016.03.609","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7\/8) hepatocellular carcinoma (HCC)","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2016.03.609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}